Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coxsackievirus A16 capsid protein VP1 is a major structural component of the icosahedral viral capsid, with 60 copies forming the vertices around the 5-fold symmetry axes. It features a β-barrel core with a hydrophobic pocket at the canyon base that binds pocket factors like sphingosine, stabilizing the capsid; receptor binding expels this factor, initiating uncoating and genome release. VP1 contains surface loops (BC, DE, EF, GH, HI) that form neutralizing epitopes targeted by antibodies and interact with receptors like SCARB2. It is critical for host cell attachment and is a key antiviral target due to its role in early infection steps.
Stabilization of VP1 hydrophobic pocket to prevent pocket factor expulsion and uncoating; Blocking receptor binding site in canyon region
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coxsackievirus A16 capsid protein VP1 (VP1).